whats-new

Sudeep Pharma IPO Day 2: Check Subscription Status & Key Highlights

Anshika Singh on 24 Nov 2025

AI Summary

The article content regarding Sudeep Pharma IPO's Day 2 subscription status and key highlights is currently unavailable, preventing the generation of a comprehensive executive summary.

Key Takeaways

**Content Not Provided for Analysis:** The absence of the blog article text means no specific data, subscription figures across investor categories, or market insights for Sudeep Pharma's IPO Day 2 can be accurately summarized.
**No Factual Reporting Possible:** Without the source material, it is impossible to report critical facts such as detailed subscription percentages, price movements, or any highlighted market trends influencing the IPO's second day.
**Implications for Investors:** Potential investors seeking immediate, factual updates on Sudeep Pharma IPO's Day 2 performance will not find specific details or actionable insights within this summary due to the missing underlying content.

Sudeep Pharma IPO Day 2: Check Subscription Status & Key Highlights

Sudeep Pharma IPO enters the second day of bidding today on November 24, 2025. The bidding window will remain open till November 25, 2025, and the allotment process is expected to be finalised the following day, i.e., November 26, 2025.

Sudeep Pharma Ltd is a manufacturer of excipients and speciality ingredients for the pharmaceutical, food, and nutrition industries. The shares of Sudeep Pharma Ltd will be listed on both NSE and BSE with a tentative listing date of November 28, 2025.

Sudeep Pharma IPO Details

Sudeep Pharma's IPO is a book-building issue of ₹895 crores. The issue comprises a fresh issue of 0.16 crore shares aggregating to ₹95 crores and an offer for sale (OFS) of 1.35 crore shares aggregating to ₹800 crores. The IPO price band is set between ₹563 and ₹593 per share. The lot size for an application is 25, and the minimum amount of investment required by a retail investor is ₹14,825 (25 shares) based on the upper price.

ICICI Securities Limited and IIFL Capital Services Limited (formerly known as IIFL Securities Limited) are the book-running lead managers for the IPO. MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited) is the registrar for the issue.